Urea cycle disorders
- 1 July 2003
- journal article
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 5 (4) , 309-319
- https://doi.org/10.1007/s11940-003-0037-5
Abstract
Urea cycle disorders comprise a group of inborn errors of metabolism that represent unique gene-nutrient interactions whose significant morbidity arises from acute and chronic neurotoxicity associated with often massive hyperammonemia. Current paradigms of treatment are focused on controlling the flux of nitrogen transfer through the hepatic urea cycle by a combination of dietary and pharmacologic approaches. Evolving paradigms include the development of cell and gene therapies. Current research is focused on understanding the pathophysiology of ammonia-mediated toxicity and prevention of neural injury.Keywords
This publication has 28 references indexed in Scilit:
- The “peripheral-type” benzodiazepine (omega 3) receptor in hyperammonemic disordersNeurochemistry International, 2002
- Neurochemistry of ammoniaNeurochemistry International, 2002
- Neurobiology of ammoniaPublished by Elsevier ,2002
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProceedings of the National Academy of Sciences, 2002
- Hyperammonemia in urea cycle disorders: Role of the nephrologistAmerican Journal of Kidney Diseases, 2001
- Role of glutamine in cerebral nitrogen metabolism and ammonia neurotoxicityMental Retardation and Developmental Disabilities Research Reviews, 2001
- Ornithine transcarbamylase deficiency: Pathogenesis of the cerebral disorder and new prospects for therapyMetabolic Brain Disease, 1997
- Prolonged Metabolic Correction in Adult Ornithine Transcarbamylase-deficient Mice with Adenoviral VectorsJournal of Biological Chemistry, 1996
- Haloperidol-induced hyperammonaemia in a child with citrullinaemiaJournal of Inherited Metabolic Disease, 1990
- Treatment of Episodic Hyperammonemia in Children with Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1984